Cardiff Oncology Inc Cash Flow-to-Debt Ratio
Cardiff Oncology Inc cash flow-to-debt ratio. Cardiff Oncology Inc (CRDF) has a Cash Flow-to-Debt Ratio of -0.36x as of December 2025, meaning its operating cash flow of $-5.97 Million could theoretically repay 0% of its total liabilities ($16.50 Million) in one year. Check CRDF cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Cardiff Oncology Inc (2009–2025)
Cash flow-to-debt ratio of Cardiff Oncology Inc from 2009 to 2025. Historical debt coverage capacity for Cardiff Oncology Inc across 17 annual periods. Check CRDF cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Cardiff Oncology Inc Cash Flow-to-Debt Ratio by Year (2009–2025)
Cardiff Oncology Inc cash flow-to-debt ratio by year from 2009 to 2025. Year-by-year debt coverage analysis for Cardiff Oncology Inc. For the full cash flow conversion analysis, see Cardiff Oncology Inc (CRDF) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.30x | $-37.92 Million | $16.50 Million | ▲ +13.1% |
| 2024 | -2.65x | $-37.69 Million | $14.24 Million | ▼ -2.0% |
| 2023 | -2.60x | $-30.89 Million | $11.90 Million | ▲ +24.4% |
| 2022 | -3.43x | $-33.82 Million | $9.85 Million | ▼ -36.0% |
| 2021 | -2.52x | $-23.04 Million | $9.13 Million | ▼ -1.6% |
| 2020 | -2.48x | $-16.31 Million | $6.57 Million | ▼ -8.1% |
| 2019 | -2.30x | $-13.27 Million | $5.78 Million | ▲ +28.8% |
| 2018 | -3.23x | $-13.20 Million | $4.09 Million | ▲ +19.8% |
| 2017 | -4.03x | $-23.28 Million | $5.78 Million | ▼ -213.8% |
| 2016 | -1.28x | $-31.04 Million | $24.18 Million | ▼ -32.0% |
| 2015 | -0.97x | $-22.12 Million | $22.75 Million | ▼ -57.0% |
| 2014 | -0.62x | $-12.73 Million | $20.55 Million | ▲ +42.7% |
| 2013 | -1.08x | $-7.32 Million | $6.76 Million | ▼ -108.2% |
| 2012 | -0.52x | $-4.93 Million | $9.50 Million | ▼ -41.9% |
| 2011 | -0.37x | $-1.93 Million | $5.27 Million | ▲ +3.4% |
| 2010 | -0.38x | $-2.09 Million | $5.51 Million | ▼ -40.3% |
| 2009 | -0.27x | $-1.23 Million | $4.55 Million | — |